Justification
Xofluza (baloxavir marboxil) 40mg tabs
75A50324F80013-LSJ
Office of Assistant Secretary for Preparedness and Response, Aspr/Orm-Sns. Pharmaceutical Preparation Manufacturing.
Awarded
$0.00 obligated so far on USAspending, September 27, 2024, contract 36F79723D0219
Get the next one like this from Office of Assistant Secretary for Preparedness and Response by email, the day it is posted.Find my opportunities
This one was awarded in 2024
9 like it are open now in pharmaceutical preparation manufacturing
- FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052
Department of Veterans Affairs, 250-Network Contract Office 10
Sources soughtNAICS 325412Anywhere in the US36C25027Q0052Closes tomorrowNov 3 - Sacubitril/Valsartan Tablets (VA-27-00014055)
Department of Veterans Affairs, Nac Pharmaceuticals
PresolicitationNAICS 325412Anywhere in the US36E79727R0007Closes tomorrowNov 3 - LIDOCAINE 5% PATCHES-REQUEST FOR INFORMATION
Department of Veterans Affairs, National Cmop Office
Sources soughtNAICS 325412Anywhere in the US36C77027Q0010Closes tomorrowNov 3
Description
As published on SAM.gov.
Xofluza (baloxavir marboxil) 40mg tablets.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Genentech Usa, Inc.
- UEI
- SA85BMHCTXK5
- CAGE
- 53VP4
- Vendor location
- South San Francisco, CA
- Contract
- 36F79723D0219
- Obligated
- $0.00, potential $4,927,972,430
- Actions
- 58 between February 1, 2024 and July 22, 2026
- Competition
- Full and Open Competition, 999 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- Pharmaceuticals
- Match
- award number 36F79723D0219 equals the contract number; awarding office not confirmed (medium confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
Points of contact
- Terri Reedterri.reed@hhs.gov